Imatinib plus Cetuximab as a Window of Opportunity Clinical Trial in Head and Neck Cancer von Bruce, J.Y., Glazer, T., Iida, M., Mehall, B., Kostecki, K.L., Yu, M., Wieland, A., Hartig, G.K., McCulloch, T.M., Trask, D., Burr, A., Harari, P.M., Kimple, R.J., Wheeler, D.L.

Volltext